IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services dedicated to using analytics and science to help healthcare stakeholders find better solutions for their patients. Formed through the merger of IMS Health and Quintiles, IQVIA has approximately 55,000 employees worldwide. Learn more

  • GB
  • 2015
    On CPHI since
Contact info
  • 210 Pentonville Road, N19JY, London, United Kingdom
Meet us at

CPHI Frankfurt 2022

Messe Frankfurt, Frankfurt, Germany
1-3 November 2022

Products from IQVIA (5)

  • Managed Markets Data & Analytic Solutions

    Product Managed Markets Data & Analytic Solutions

    Fundamental to the success of your market access strategy is clear visibility into payer, provider and patient behavior. IQVIA’s comprehensive real-world database includes lifecycle transactions, which offer the critical level of detail required to untangle the complex interaction of payer utilization managem...
  • Brand and Promotional Analysis

    Product Brand and Promotional Analysis

    Powered by the IQVIA CORE™, our promotional analysis can help you understand the trajectory of your brand and measure its progress along the way. We can help you see where you are today, where you’re going and help you make adjustments as part of your path forward. Find out what you need to know about • Sh...
  • Clinical Trial Optimization

    Product Clinical Trial Optimization

    Faster market access by optimized clinical trials Every study is unique and stakes are high. In order to ensure success IQVIA uses all available resources - therapeutical expertise, latest technology, advanced analytics and proactive approach. This allows us to effectively search for research centers and r...
  • Health Economics & Value

    Product Health Economics & Value

    Even if your objective seems clear–demonstrate the value of your product – it is rarely a simple task. That is because there is no single story or piece of evidence when you speak to audiences around the world: regulators, health technology assessment (HTA) bodies, payers, providers and patients. IQVIA acc...
  • Launch Performance by Patient Segment

    Product Launch Performance by Patient Segment

    Each launch has a million moving pieces. Almost all are based on what you know about your market. Which patients are using which products? What is their patient journey? What types of physicians prescribe them? How do treatments and costs vary by geography or provider? Primary market research provides some of...

IQVIA Resources (3)

  • News CPHI releases Pharma Trends 2022 report

    CPHI has launched its forward-looking pharma trend report for 2022 and it is now available to read on CPHI Online.
  • Webinar Developments in the Cold-Chain

    In this webinar, originally broadcast as part of the Pharmapack Europe show, Stefan Lutzmayer, Consultant, IQVIA discusses how as biologics and specialty medicines increase in importance in global healthcare, especially when access to medicines and biosimilars become growth areas, this brings various opportunities in developing the logistical network that delivers these medicines to patients in a temperature-controlled environment. This session explores the rapid growth of cold-chain medicines and seek to understand their impact on health provision and the environment.
  • Webinar Trends in Drug Delivery

    In this webinar, originally broadcast as part of the Pharmapack Europe show, speaker Aurelio Areas, Engagement Manager, IQVIA will give us a look at the global outlook of the pharma industry as it emerges from the pandemic with a focus on drug delivery trends. This session analyses current dynamics in drug delivery devices and look at emerging growth areas such as the rise of self-administration, connectivity and the impact of devices on our environment.